Overview
Tomonori Hirashima practices practicing medicine in Higashi-osaka, Japan.
Hirashima is highly rated in 7 conditions, according to our data. Their clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, EGFR Positive Lung Cancer, Pleural Effusion, and Endoscopy.
They are actively involved in clinical research, co-authoring 124 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Tomonori Hirashima
Is Tomonori Hirashima a top-rated expert for Non-Small Cell Lung Cancer (NSCLC)?
MediFind is an objective health platform that identifies experts based on real-world data. Tomonori Hirashima is classified as an Elite expert for Non-Small Cell Lung Cancer (NSCLC), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Tomonori Hirashima participate in research or clinical trials?
Yes. Tomonori Hirashima has published 124 articles and abstracts on conditions like Non-Small Cell Lung Cancer (NSCLC). You can view a list of Tomonori Hirashima's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Lung CancerHirashima isElite. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)
- Distinguished
- EGFR Positive Lung CancerHirashima isDistinguished. Learn about EGFR Positive Lung Cancer.
- Pleural EffusionHirashima isDistinguished. Learn about Pleural Effusion.
- Advanced
- Metastatic Pleural TumorHirashima isAdvanced. Learn about Metastatic Pleural Tumor.
- ParonychiaHirashima isAdvanced. Learn about Paronychia.
- Small Cell Lung Cancer (SCLC)Hirashima isAdvanced. Learn about Small Cell Lung Cancer (SCLC).
- Experienced
- Acute Interstitial PneumoniaHirashima isExperienced. Learn about Acute Interstitial Pneumonia.
- AgranulocytosisHirashima isExperienced. Learn about Agranulocytosis.
- Bone TumorHirashima isExperienced. Learn about Bone Tumor.
- COVID-19Hirashima isExperienced. Learn about COVID-19.
- Diabetic KetoacidosisHirashima isExperienced. Learn about Diabetic Ketoacidosis.
- DiarrheaHirashima isExperienced. Learn about Diarrhea.
- EmpyemaHirashima isExperienced. Learn about Empyema.
- EndoscopyHirashima isExperienced. Learn about Endoscopy.
- Follicular Thyroid CancerHirashima isExperienced. Learn about Follicular Thyroid Cancer.
- Hypersensitivity PneumonitisHirashima isExperienced. Learn about Hypersensitivity Pneumonitis.
- Interstitial Lung DiseaseHirashima isExperienced. Learn about Interstitial Lung Disease.
- Interstitial NephritisHirashima isExperienced. Learn about Interstitial Nephritis.
- Lung AdenocarcinomaHirashima isExperienced. Learn about Lung Adenocarcinoma.
- Lung MetastasesHirashima isExperienced. Learn about Lung Metastases.
- MesotheliomaHirashima isExperienced. Learn about Mesothelioma.
- PneumoniaHirashima isExperienced. Learn about Pneumonia.
- PrognathismHirashima isExperienced. Learn about Prognathism.
- Pseudomembranous ColitisHirashima isExperienced. Learn about Pseudomembranous Colitis.
- Pulmonary EmbolismHirashima isExperienced. Learn about Pulmonary Embolism.